| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00005792-197009000-00004 |
| P953 | full work available at URL | https://journals.lww.com/00005792-197009000-00004 |
| P698 | PubMed publication ID | 4924695 |
| P2093 | author name string | H. Latta | |
| C. M. Pearson | |||
| E. V. Barnett | |||
| H. C. Gonick | |||
| R. L. Vernier | |||
| T. M. Stanley | |||
| L. Dornfeld | |||
| D. A. Adams | |||
| R. C. Austin | |||
| J. P. Drinkard | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | azathioprine | Q18939 |
| P304 | page(s) | 411-432 | |
| P577 | publication date | 1970-09-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Azathioprine and prednisone in the treatment of adults with lupus nephritis. Clinical, histological, and immunological changes with therapy | |
| P478 | volume | 49 |
| Q69472540 | Acute Lupus Pneumonitis: Response to Azathioprine Therapy |
| Q39897265 | Antineoplastic and immunosuppressive drugs. II. Therapeutic uses |
| Q39406225 | Antinuclear antibodies (ANA): Immunologic and clinical significance |
| Q39362656 | Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis |
| Q35968394 | Challenges in bringing the bench to bedside in drug development for SLE. |
| Q40497391 | Clinical use of immunosuppressive drugs: part I |
| Q39536979 | Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis |
| Q39937928 | Corticosteroid Therapy of the Collagen Vascular Disorders |
| Q34235737 | Cyclophosphamide Therapy in Wegener's Granulomatosis |
| Q91934535 | Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases |
| Q68952724 | Drug-induced cholestasis |
| Q70676226 | Experience of immunosuppressive therapy of glomerular disease in adults |
| Q45049211 | Extramembranous glomerulonephritis in childhood: Relationship to systemic lupus erythematosus |
| Q66910818 | Glomerulonephritis in SLE |
| Q44009488 | Glomerulonephritis — 1974 |
| Q44087896 | Hepatic dysfunction after renal transplantation in children |
| Q39923325 | Immunosuppression — Agents, Procedures, Speculations and Prognosis |
| Q36269226 | Immunosuppressive Therapy in Rheumatic Disease |
| Q40883177 | Immunosuppressive drug therapy in lupus nephritis |
| Q70450142 | Immunosuppressive therapy. Guidelines for drug dosage. Depression of bone marrow granulocyte reserves in systemic lupus erythematosus |
| Q67444638 | Long-term azathioprine-corticosteroid therapy in lupus nephritis and idiopathic nephrotic syndrome |
| Q66912444 | Long-term maintenance therapy with azathioprine in systemic lupus erythematosus |
| Q67337023 | On survivorship in the nephritis of systemic lupus erythematosus |
| Q33286668 | Prognostic factors in systemic lupus erythematosus |
| Q33824546 | Recent advances in the immunopathogenesis of systemic lupus erythematosus |
| Q69254751 | Renal transplantation in young children |
| Q69633509 | Short-term prognosis of severe proliferative lupus nephritis |
| Q38791636 | The treatment of lupus nephritis |
| Q70388077 | Therapeutic studies in NZB/W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combination |
Search more.